Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management

Multiple myeloma (MM) is associated with increased risk of infection, but little is known regarding antibody levels against specific bacteria. We assessed levels of polyclonal immunoglobulin and antibacterial antibodies in patients recruited to the TEAMM trial, a randomised trial of antibiotic proph...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Cancer J
Päätekijät: Chicca, Ilaria J., Heaney, Jennifer L. J., Iqbal, Gulnaz, Dunn, Janet A., Bowcock, Stella, Pratt, Guy, Yong, Kwee L., Planche, Timothy D., Richter, Alex, Drayson, Mark T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7642409/
https://ncbi.nlm.nih.gov/pubmed/33149136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00370-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia